Products from TargetMol

TargetMol

TargetMol, based in Boston, Massachusetts, was founded in 2015 and is a drug screening expert in the life science community. The company offers diverse compound libraries, including FDA-approved libraries, and covers a broad spectrum of small molecule compounds such as inhibitors and agonists as well as recombinant proteins and natural products. TargetMol's products are used by researchers worldwide in areas such as cancer research, neurobiology, inflammation, immunology and metabolism.

More information at: www.targetmol.com

Go to the catalogs of TargetMol

11566 from 12274 pages
No results were found for the filter!
BAY-728
BAY-728

Item number: TGM-T75101-2mg

Description: BAY-728 serves as a negative control for BAY-805, a potent and selective inhibitor of USP21 [1]. Target: Others
MW: 507.57 D
128.00€ *
Review
COVID-19 Spike Protein mRNA(N1-Me-Pseudo UTP)
COVID-19 Spike Protein mRNA(N1-Me-Pseudo UTP)

Item number: TGM-T75102-50mg

Description: The COVID-19 Spike Protein mRNA, responsible for expressing the COVID-19 spike protein, is crucial for evaluating RNA delivery, translation efficiency, and cell viability. Positioned on the membrane surface, this spike protein facilitates virus entry into cells by binding to host cell membrane receptors...
Please request pricing for this article.
Review
CD19 CAR mRNA
CD19 CAR mRNA

Item number: TGM-T75103-50mg

Description: CD19 CAR mRNA is designed to express the CD19 chimeric antigen receptor (CAR) protein, pivotal in chimeric antigen receptor T cell (CAR-CD19) immunotherapy. This receptor targets CD19, a membrane antigen crucial for B cell proliferation, differentiation, activation, and antibody synthesis, playing a...
Please request pricing for this article.
Review
CD19 CAR circRNA
CD19 CAR circRNA

Item number: TGM-T75104-50mg

Description: CD19 CAR circRNA, expressing CD19 car protein, is utilized in chimeric antigen receptor T cell immunotherapy (CAR-CD19). This compound involves a chimeric antigen receptor, CD19, a CD molecule present on B cells (i.e., leukocyte differentiation antigen), crucial for B cell proliferation,...
Please request pricing for this article.
Review
OICR12694 TFA
OICR12694 TFA

Item number: TGM-T75105-50mg

Description: OICR12694 (JNJ-65234637) TFA, an orally active B cell lymphoma 6 (BCL6) inhibitor [1], demonstrates effectiveness in targeting BCL6 pathways. Target: Others
CAS 2360625-98-3
Please request pricing for this article.
Review
ARC186
ARC186

Item number: TGM-T75106-50mg

Description: ARC186 is a highly potent aptamer that serves as a complement inhibitor by blocking the convertase-catalyzed activation of C5. Target: Others
MW: 120702.76 D
Please request pricing for this article.
Review
LNP Lipid-4
LNP Lipid-4

Item number: TGM-T75111-50mg

Description: LNP Lipid-4 (Compound 8-8) is a lipid compound integral to the synthesis of lipid nanoparticle compositions, demonstrating potential for the transport of biologically active substances [1]. Target: Others
CAS 2795397-84-9
MW: 886.38 D
Please request pricing for this article.
Review
CD19 car mRNA-LNP
CD19 car mRNA-LNP

Item number: TGM-T75114-50mg

Description: CD19 car mRNA-LNP, a lipid nanoparticle (LNP) encapsulating CD19 car mRNA, is instrumental in assessing RNA delivery, translation efficacy, and cell viability among other applications. This compound is pivotal for chimeric antigen receptor T cell immunotherapy (CAR-CD19), leveraging the CD19 molecule -...
Please request pricing for this article.
Review
CD19 car circRNA-LNP
CD19 car circRNA-LNP

Item number: TGM-T75115-50mg

Description: CD19 car circRNA-LNP, a lipid nanoparticle containing CD19 car circRNA, is designed for applications in RNA delivery, translation efficiency, and cell viability assessment. This compound is utilized in chimeric antigen receptor T cell immunotherapy (CAR-CD19), leveraging CD19 car, a chimeric antigen...
Please request pricing for this article.
Review
COVID-19 Spike Protein mRNA-LNP
COVID-19 Spike Protein mRNA-LNP

Item number: TGM-T75116-50mg

Description: COVID-19 Spike Protein mRNA-LNP is a lipid nanoparticle (LNP) formulated with the novel coronavirus pneumonia spike protein, positioned on the membrane surface. It is designed for applications such as RNA delivery, translation efficiency, and cell viability assessment. This spike protein facilitates the...
Please request pricing for this article.
Review
Py-MAA-Val-Cit-PAB-DX8951
Py-MAA-Val-Cit-PAB-DX8951

Item number: TGM-T75117-50mg

Description: Py-MAA-Val-Cit-PAB-DX8951, a purine toxin, serves as an intermediate in the synthesis of antibody-drug conjugates [1]. Target: Others
CAS 2504068-37-3
MW: 1164.26 D
Please request pricing for this article.
Review
KRASG12C IN-2
KRASG12C IN-2

Item number: TGM-T75119-50mg

Description: KRASG12C IN-2 (compound 17) is an orally active KRAS G12C inhibitor that effectively suppresses tumor growth in mice [1]. Target: Others
Please request pricing for this article.
Review
11566 from 12274 pages